Zymvol Biomodeling, a CataloniaBio & HealthTech member, wins Phase II of the SME Instrument funded by the European Commission. The start-up will receive €1.3 million for the project Unlock-Edd: Unlock next generation computer guided Enzyme Discovery & Design. 

The project goals are to keep improving the proprietary technology by implementing artificial intelligence approaches, the development of a computational pipeline for enzyme kits, and the development of proprietary enzymes.

Enzymes (biocatalysts) are increasingly used in a number of different industrial sectors with the aim to operate in a more sustainable way. Zymvol, based in Barcelona, is specialised in in silico enzyme engineering for the chemical, pharmaceutical, food and biotech sectors. Nowadays it works with customers in 10 countries.

On the other hand, this week  Zymvol joined Rosa Maria Abadie as Head of Legal. She is the IP&IT Director at Bellavista.

We recommend this video of CataloniaBioHT interviewing them: